THYROCAREHealthcare Service Provider
Thyrocare Technologies Ltd — Profit & Loss Statement
₹349.55
-2.13%
Thyrocare Technologies Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Expenses | 551.56 Cr | 479.17 Cr | 442.05 Cr | 387.00 Cr |
| Rent Expense Supplemental | 1.81 Cr | 4.15 Cr | 5.61 Cr | 3.00 Cr |
| Diluted Average Shares | 5.31 Cr | 5.30 Cr | 5.30 Cr | 5.30 Cr |
| Basic Average Shares | 5.30 Cr | 5.29 Cr | 5.29 Cr | 5.29 Cr |
| Diluted EPS | 17.23 | 13.34 | 12.14 | 33.25 |
| Basic EPS | 17.28 | 13.37 | 12.16 | 33.30 |
| Diluted NI Availto Com Stockholders | 91.51 Cr | 70.76 Cr | 64.49 Cr | 176.14 Cr |
| Net Income Common Stockholders | 91.51 Cr | 70.76 Cr | 64.49 Cr | 176.14 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 91.51 Cr | 70.76 Cr | 64.49 Cr | 176.14 Cr |
| Minority Interests | 0.76 Cr | 1.27 Cr | 0.13 Cr | 0.00 |
| Net Income Including Noncontrolling Interests | 90.75 Cr | 69.49 Cr | 64.36 Cr | 176.14 Cr |
| Net Income Continuous Operations | 90.75 Cr | 69.49 Cr | 64.36 Cr | 176.14 Cr |
| Tax Provision | 54.69 Cr | 26.49 Cr | 24.23 Cr | 51.58 Cr |
| Pretax Income | 145.44 Cr | 95.98 Cr | 88.59 Cr | 227.72 Cr |
| Other Non Operating Income Expenses | 0.74 Cr | 0.83 Cr | 0.44 Cr | 1.80 Cr |
| Special Income Charges | 0.03 Cr | -0.93 Cr | 0.43 Cr | 21.52 Cr |
| Other Special Charges | -0.03 Cr | 0.93 Cr | -0.43 Cr | -21.52 Cr |
| Net Non Operating Interest Income Expense | 1.36 Cr | -2.82 Cr | -3.45 Cr | -2.50 Cr |
| Total Other Finance Cost | 0.69 Cr | 1.33 Cr | 2.48 Cr | 0.84 Cr |
| Interest Expense Non Operating | 3.05 Cr | 4.20 Cr | 2.35 Cr | 2.37 Cr |
| Interest Income Non Operating | 5.10 Cr | 2.71 Cr | 1.38 Cr | 0.71 Cr |
| Operating Income | 135.79 Cr | 92.71 Cr | 84.62 Cr | 201.86 Cr |
| Operating Expense | 360.40 Cr | 312.47 Cr | 278.82 Cr | 217.31 Cr |
| Other Operating Expenses | 99.14 Cr | 87.78 Cr | 84.82 Cr | 79.81 Cr |
| Depreciation And Amortization In Income Statement | 55.26 Cr | 47.01 Cr | 38.71 Cr | 33.87 Cr |
| Depreciation Income Statement | 55.26 Cr | 47.01 Cr | 38.71 Cr | 33.87 Cr |
| Selling General And Administration | 77.42 Cr | 65.67 Cr | 43.53 Cr | 39.50 Cr |
| Selling And Marketing Expense | 40.30 Cr | 32.66 Cr | 20.18 Cr | 22.12 Cr |
| General And Administrative Expense | 37.12 Cr | 33.01 Cr | 23.35 Cr | 17.38 Cr |
| Rent And Landing Fees | 1.81 Cr | 4.15 Cr | 5.61 Cr | 3.00 Cr |
| Gross Profit | 496.19 Cr | 405.18 Cr | 363.44 Cr | 419.17 Cr |
| Cost Of Revenue | 191.16 Cr | 166.70 Cr | 163.23 Cr | 169.69 Cr |
| Total Revenue | 687.35 Cr | 571.88 Cr | 526.67 Cr | 588.86 Cr |
| Operating Revenue | 687.35 Cr | 571.88 Cr | 526.67 Cr | 588.86 Cr |
| Tax Effect Of Unusual Items | 3.32 Cr | 1.34 Cr | 1.59 Cr | 6.06 Cr |
| Tax Rate For Calcs | 0.38 | 0.28 | 0.27 | 0.23 |
| Normalized EBITDA | 194.91 Cr | 142.34 Cr | 123.85 Cr | 237.22 Cr |
| Total Unusual Items | 8.84 Cr | 4.85 Cr | 5.80 Cr | 26.74 Cr |
| Total Unusual Items Excluding Goodwill | 8.84 Cr | 4.85 Cr | 5.80 Cr | 26.74 Cr |
| Net Income From Continuing Operation Net Minority Interest | 91.51 Cr | 70.76 Cr | 64.49 Cr | 176.14 Cr |
| Reconciled Depreciation | 55.26 Cr | 47.01 Cr | 38.71 Cr | 33.87 Cr |
| Reconciled Cost Of Revenue | 191.16 Cr | 166.70 Cr | 163.23 Cr | 169.69 Cr |
| EBITDA | 203.75 Cr | 147.19 Cr | 129.65 Cr | 263.96 Cr |
| EBIT | 148.49 Cr | 100.18 Cr | 90.94 Cr | 230.09 Cr |
| Net Interest Income | 1.36 Cr | -2.82 Cr | -3.45 Cr | -2.50 Cr |
| Interest Expense | 3.05 Cr | 4.20 Cr | 2.35 Cr | 2.37 Cr |
| Interest Income | 5.10 Cr | 2.71 Cr | 1.38 Cr | 0.71 Cr |
| Normalized Income | 85.99 Cr | 67.25 Cr | 60.28 Cr | 155.46 Cr |
| Net Income From Continuing And Discontinued Operation | 91.51 Cr | 70.76 Cr | 64.49 Cr | 176.14 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Thyrocare Technologies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.